Literature DB >> 17408695

Stroke as the first manifestation of concealed cancer.

Hyung-Min Kwon1, Bong Su Kang, Byung-Woo Yoon.   

Abstract

BACKGROUND AND
PURPOSE: Trousseau's syndrome (TS) is defined as a malignancy-related thromboembolism occurring in patients with an underlying or undiagnosed malignancy. Stroke seldom occurs as the first manifestation of a cancer. We investigated the clinical and radiological features of patients with TS.
METHODS: We reviewed the clinical, pathologic, and radiological records of consecutive stroke patients, whose cancers were diagnosed at stroke presentation. Cancer-related stroke was defined if no definite cause was confirmed and malignancy was detected within 6 months of first stroke onset without cancer-related treatment. All patients underwent brain diffusion-weighted MRI (DWI), MR angiography, and echocardiography. The sizes, numbers, and locations of all hyperintense lesions in the DWI were noted.
RESULTS: Ten patients were finally analyzed. Histologically, cancers were often proven to adenocarcinomas (50%, 5/10) of advanced stage. Six of 10 patients tested (60%) had elevated D-dimer. Seven of the 10 patients (70%) showed bihemispheric anterior and posterior involvement. DWI features showed numerous small and medium or large lesions in multiple territories in 9 patients (90%).
CONCLUSIONS: The authors emphasize that when presented with multiple bihemispheric infarctions on DWI and an unknown etiology, the neurologist must consider the existence of a concealed cancer.

Entities:  

Mesh:

Year:  2007        PMID: 17408695     DOI: 10.1016/j.jns.2007.02.035

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  19 in total

1.  Predictors of unknown cancer in patients with ischemic stroke.

Authors:  Sonia Quintas; Jacobo Rogado; Pedro Gullón; Vilma Pacheco-Barcia; Julio Dotor García-Soto; Gemma Reig-Roselló; Rebeca Mondéjar; Ramón Colomer; Jose Vivancos
Journal:  J Neurooncol       Date:  2018-01-08       Impact factor: 4.130

2.  Procedural and clinical outcomes of endovascular recanalization therapy in patients with cancer-related stroke.

Authors:  Seunguk Jung; Cheolkyu Jung; Jae Hyoung Kim; Byung Se Choi; Yun Jung Bae; Leonard Sunwoo; Ho Geol Woo; Jun Young Chang; Beom Joon Kim; Moon-Ku Han; Hee-Joon Bae
Journal:  Interv Neuroradiol       Date:  2018-05-23       Impact factor: 1.610

3.  Clinical manifestation of cancer related stroke: retrospective case-control study.

Authors:  Jeong-Min Kim; Keun-Hwa Jung; Kee Hong Park; Soon-Tae Lee; Kon Chu; Jae-Kyu Roh
Journal:  J Neurooncol       Date:  2013-01-09       Impact factor: 4.130

4.  Cortical blindness due to cerebral infarct in advanced pancreatic cancer.

Authors:  Nivedita Nimesh; Sanjeev Kumar Verma; Sanjiv Kumar Gupta
Journal:  BMJ Case Rep       Date:  2019-08-01

5.  Stroke and Cancer- A Complicated Relationship.

Authors:  Jennifer L Dearborn; Victor C Urrutia; Steven R Zeiler
Journal:  J Neurol Transl Neurosci       Date:  2014

6.  Three-Territory DWI Acute Infarcts: Diagnostic Value in Cancer-Associated Hypercoagulation Stroke (Trousseau Syndrome).

Authors:  P F Finelli; A Nouh
Journal:  AJNR Am J Neuroradiol       Date:  2016-06-30       Impact factor: 3.825

7.  Multiple embolic cerebral infarcts as the first manifestation of metastatic ovarian cancer.

Authors:  Laura M Bond; Darko Skrobo
Journal:  BMJ Case Rep       Date:  2015-10-06

8.  Biomarkers and mortality after transient ischemic attack and minor ischemic stroke: population-based study.

Authors:  Stefan Greisenegger; Helen C Segal; Annette I Burgess; Debbie L Poole; Ziyah Mehta; Peter M Rothwell
Journal:  Stroke       Date:  2015-02-03       Impact factor: 7.914

9.  Clinical Features of Cancer Associated Ischemic Stroke.

Authors:  Nilüfer Yeşilot; Esme Ekizoğlu; Oğuzhan Çoban
Journal:  Noro Psikiyatr Ars       Date:  2018-05-04       Impact factor: 1.339

10.  Clues to occult cancer in patients with ischemic stroke.

Authors:  Suk Jae Kim; Jae Hyun Park; Mi-Ji Lee; Yun Gyoung Park; Myung-Ju Ahn; Oh Young Bang
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.